Log In
Print this Print this

Siklos, hydroxycarbamide

  Manage Alerts
Collapse Summary General Information
Company addmedica S.A.S.
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSickle cell disease
Indication DetailsTreat sickle cell anemia (prevent painful vaso-occlusive crises)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today